deferiprone has been researched along with Complication, Postoperative in 2 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, T | 1 |
| White, A | 1 |
| Meades, K | 1 |
| Bala, C | 1 |
| Efthimia, V | 1 |
| Neokleous, N | 1 |
| Agapidou, A | 1 |
| Economou, M | 1 |
| Vetsiou, E | 1 |
| Teli, A | 1 |
| Perifanis, V | 1 |
2 other studies available for deferiprone and Complication, Postoperative
| Article | Year |
|---|---|
Novel topical therapy for corneal blood staining.
Topics: Aged; Blood; Cornea; Corneal Diseases; Deferiprone; Humans; Iron Chelating Agents; Male; Ophthalmic | 2017 |
Nephrolithiasis in beta thalassemia major patients treated with deferasirox: an advent or an adverse event? A single Greek center experience.
Topics: Adult; Benzoates; beta-Thalassemia; Chelation Therapy; Child; Child, Preschool; Deferasirox; Deferip | 2013 |